Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Eli Lilly gets rights to Marcadia's glucagon analog program

Executive Summary

Marcadia Biotech Inc. (developing therapeutics for obesity and diabetes) has licensed Eli Lilly & Co. exclusive global marketing rights to its preclinical short-acting glucagon analog MAR531 and backup compounds for hypoglycemia.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies

UsernamePublicRestriction

Register